The size of the Latin American cardiac assist devices market was estimated at USD 134.82 Million in 2020. It is further estimated to worth USD 193.11 Million by 2025, growing at a CAGR of 7.45% from 2020 to 2025.
These devices are normally employed in patients suffering from End-Stage Congestive Heart Failure, where the odds of survival through medications alone are minimal. South American countries have greater mortality and morbidity from stroke than from coronary heart disease (CHD).
The scarcity of donor organs due to less awareness about organ donation has furthered steered the CAD Market's development. Various pipeline products are going through clinical trials to provide vigorous clinical data on the safety and efficacy of the devices. The approval of novel technologically advanced products will further increase the demand for cardiac assist devices in the future.
To meet the increasing demand for cardiac therapies in Latin American countries, Cardiac Assist Devices (CAD) are used. These devices are used as a Bridge-To-Transplantation (BTT), Bridge-To-Recovery (BTR), or Destination Therapy (DT), depending on the requirement of the patient and the severity of the disease. The upsurge in the aging population, along with the scarcity of donor organs, has also added to the growing need for the development of these devices.
The existence of alternative treatments like a pacemaker, heart transplantation, etc. The risks associated with device implantation, such as respiratory failure, development of blood clots, and device failure, restrain the market growth. Adding to these, surgical impediments such as kidney failure, bleeding, Infection, and occurrence of stroke are also acting as a barrier in the adoption of such devices.
This research report on the Latin American Cardiac Assist Devices Market segmented and sub-segmented into the following categories:
Regionally, The Latin America region accounts for about 6.5% of the global cardiac assist devices market.
Noteworthy companies operating in the Latin American cardiac assist devices market are Thoratec Corporation, MAQUET GmbH & Co, Teleflex Incorporated, Berlin Heart GmbH, Abiomed, Inc., HeartWare International, SynCardia Systems, Inc, Jarvik Heart, Inc., and Terumo Corporation. BiVacor Pty Ltd, Braile Biomedica Ltd., Calon Cardio-Technology Ltd., CardiacAssist, Inc., CardioBridge GmbH, Carmat SAS, Cleveland Heart, Inc., CorAssist Cardiovascular Ltd., Evaheart Medical USA, Inc., Leviticus Cardio Ltd., are the leading market players with dominance over 60% of the market.
Thoratec Corporation and Berlin Heart are the prominent players in the VAD segment, whereas Teleflex and MAQUET are dominant players in the Intra-Aortic Balloon Pumps (IABP) segment. SynCardia is the foremost company to provide the only Food and Drug Administration (FDA) approved Total Artificial Heart (TAH).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Global Cardiac Assist Devices Market, by Type
5.1.1 Ventricular Assist Devices (VAD)
22.214.171.124 Right Ventricular Assist Device (RVAD
126.96.36.199 Left Ventricular Assist Device (LVAD)
188.8.131.52 Bi-Ventricular Assist Device (Bi-VAD
184.108.40.206 External Ventricular Assist Devices
5.1.2 Intra-Aortic Balloon Pumps (IABP)
5.1.3 Total Artificial Heart (TAH)
6.5 Rest of Latin America
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thoratec Corporation
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Berlin Heart GmbH
8.3 Abiomed, Inc
8.4 HeartWare International
8.5 Jarvik Heart, Inc
8.6 Terumo Corporation
8.7 Calon Cardio-Technology Ltd.
8.8 CardiacAssist, Inc.
8.9 CardioBridge GmbH
8.10 Carmat SAS
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities